The landscape of wearable sensors in clinical trials has proven difficult to navigate for many, including sponsors and vendors.
Collaboration around the development of digital endpoints with a focus on data quality, validation, compliance, and clinical utility is required to extract the most from new digital technologies.
In this 20-minute presentation, VivoSense Chief Science Officer, Kate Lyden, PhD., and Jeremy Wyatt, ActiGraph CEO, discuss:
Fill out the form to watch the presentation today!